Search - tctmd.com

Displaying 481 - 500 of 2624

Sort: Relevancy | Date

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

Presentation

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Presenter: William Wilson

December 22, 2015

News Daily News

德国数据显示 TAVR 的出现对临床实践模式产生影响

L.A. McKeown

December 16, 2015

News Daily News

他汀类药物对主动脉钙化的效果？影像学研究再次引发低密度脂蛋白在主动脉瓣疾病中作用的争论

Shelley Wood

December 16, 2015

News Daily News

¿Estatinas para el Manejo de la Calcificación Aórtica? Un Estudio de Imágenes Debate sobre el Papel de las LBD en la Enfermedad de la Válvula Aórtica

Shelley Wood

December 16, 2015

News Daily News

Statins for Aortic Calcification? Imaging Study Reopens Debate Over LDL’s Role in Aortic Valve Disease

Shelley Wood

December 16, 2015

News Daily News

German Data Show Impact of TAVR Introduction on Clinical Practice Patterns

L.A. McKeown

December 16, 2015

News Daily News

Datos Alemanes Confirman el Impacto de la Introducción de la TAVR en los Patrones de Práctica Clínica

L.A. McKeown

December 16, 2015

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

Presentation

Effect of Availability of TAVR on Clinical Practice

Presenter: Jochen Rein?hl

December 15, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

News Daily News

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

L.A. McKeown

December 07, 2015

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Daily News

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

L.A. McKeown

December 07, 2015

News Daily News

Cuantos Más Centros de EE.UU. realizan TAVR, Más Variación en los Resultados de los Pacientes

Todd Neale

December 07, 2015

News Daily News

As the Number of US TAVR Centers Grows, Patient Outcomes Vary

Todd Neale

December 07, 2015

News Daily News

As the Number of US TAVR Centers Grows, Patient Outcomes Vary

Todd Neale

December 07, 2015

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

Advertisement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

德国数据显示 TAVR 的出现对临床实践模式产生影响

他汀类药物对主动脉钙化的效果？影像学研究再次引发低密度脂蛋白在主动脉瓣疾病中作用的争论

¿Estatinas para el Manejo de la Calcificación Aórtica? Un Estudio de Imágenes Debate sobre el Papel de las LBD en la Enfermedad de la Válvula Aórtica

Statins for Aortic Calcification? Imaging Study Reopens Debate Over LDL’s Role in Aortic Valve Disease

German Data Show Impact of TAVR Introduction on Clinical Practice Patterns

Datos Alemanes Confirman el Impacto de la Introducción de la TAVR en los Patrones de Práctica Clínica

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

Effect of Availability of TAVR on Clinical Practice

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

Cuantos Más Centros de EE.UU. realizan TAVR, Más Variación en los Resultados de los Pacientes

As the Number of US TAVR Centers Grows, Patient Outcomes Vary

As the Number of US TAVR Centers Grows, Patient Outcomes Vary

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content